Patient, health and multi-omic datasets for research, drug development and clinical trials
PRECISION MEDICINE DATA
Connect to our
Precision Medicine
Data Catalog
100M +
> 30
Global data providers including biobanks and national initiatives
+200
Diseases, conditions and research areas to align to your R&D requirements
Accelerate research, drug discovery and clinical trial success by securely accessing diverse multi-omic and health datasets. Includes WES, WGS, RNA-seq data.
Our LIVE federated datasets
Last updated: Feb 2024Cardiometabolic diseases encompass conditions affecting the heart, blood vessels, and metabolism.
Central Nervous System (CNS) conditions involve disorders affecting the brain and spinal cord.
Control populations are essential to minimize bias and provide a basis for comparison, thereby ensuring the validity and reliability of a study.
Dermatological conditions are disorders that affect the skin, hair, and nails, for example eczema, psoriasis, acne, and skin cancer.
Endocrinology is the study of hormones, their physiological functions, and the diseases and disorders associated with hormone imbalances.
Gastrointestinal conditions encompass a spectrum of disorders affecting the digestive tract.
Hearing conditions consist of a broad spectrum of disorders from temporary hearing loss to permanent hearing impairment.
Immunological and inflammatory conditions involve dysregulation of the immune system.
Mental health conditions encompass many disorders that affect mood, thinking, and behavior, and include depression and anxiety disorders.
Oncological conditions involve the development of abnormal and malignant growths, known as tumors.
Ophthalmic conditions are disorders that affect the eyes and visual system such as cataracts, glaucoma and macular degeneration.
Respiratory conditions affect the lungs and airways, such as asthma, chronic obstructive pulmonary disease (COPD) and pneumonia.
Rheumatological conditions affect the joints, muscles, and connective tissues, and include rheumatoid arthritis, lupus, and fibromyalgia.
Rare diseases are characterized by their low prevalence in the population, yet still impact many millions of patients worldwide.
Learn more about Lifebit's Data Catalog
Discover the Lifebit drug discovery module, which seamlessly integrates genomics data processing through advanced Nextflow pipelines.
Discover our drug discovery module
Read about our partnerships with two innovative population genomic initiatives
in Mexico and Brazil to help diversify genomic research and reduce health inequality in Latin America.
Read about our latest data partners
Catch up on our webinar focused on the impact of diverse genomic and clinical data on target validation, drug discovery, and patient outcomes.
Maximize data diversity